At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 24, 2026 at 07:30 ET
Palvella Therapeutics announced it will report its full year 2025 financial results on March 31, 2026, followed by a conference call to discuss the results and provide a corporate update. The press release contains no actual financial data, only logistical details about the upcoming earnings announcement.
- Palvella Therapeutics will report full year 2025 financial results on March 31, 2026, before market open.
- Management will host a conference call at 8:30 a.m. ET on March 31, 2026, to discuss results and provide a corporate update.
- No financial results, guidance, or operational updates were disclosed in this release.
- Company remains in clinical-stage development with no FDA-approved therapies yet.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access